Mesoblast
MESO
44 hedge funds and large institutions have $7.97M invested in Mesoblast in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 6 closing their positions.
152% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $714K
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
5% more funds holding
Funds holding: 42 → 44 (+2)
1% more capital invested
Capital invested by funds: $7.89M → $7.97M (+$85.6K)
0.01% less ownership
Funds ownership: 0.18% → 0.17% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$761K |
| 2 |
Millennium Management
New York
|
+$581K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$97.5K |
| 4 |
BlackRock
New York
|
+$94.8K |
| 5 |
DTL
Dynamic Technology Lab
Singapore
|
+$56.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MGIM
M&G Investment Management
London,
United Kingdom
|
-$1.28M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$283K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$266K |
| 4 |
Jane Street
New York
|
-$187K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$145K |
MESO Hedge Fund Activity: Q1 2023 in Review
44 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2023, worth a combined $7.97M — up 1.1% from $7.89M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MESO positions and 6 closed out — a net gain of 2 holders — while 13 added to existing stakes and 7 trimmed.
The largest buyer was State Street, opening a new position worth an estimated $761K. The largest seller was M&G Investment Management, cutting an estimated $1.28M.
- 44 institutional investors held Mesoblast (MESO) as of Q1 2023, up from 42 in Q4 2022.
- Funds reported $7.97M of Mesoblast stock for Q1 2023, up 1.1% quarter-over-quarter.
- 8 funds opened new Mesoblast positions in Q1 2023 and 6 closed out, a net change of +2 holders.
- The largest Mesoblast buyer in Q1 2023 was State Street, an estimated $761K added.
- The largest Mesoblast seller in Q1 2023 was M&G Investment Management, an estimated $1.28M sold.
Based on aggregated 13F filings for Q1 2023.